Published in J Virol on November 01, 1991
Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res (1992) 4.58
Cap-dependent and cap-independent translation by internal initiation of mRNAs in cell extracts prepared from Saccharomyces cerevisiae. Mol Cell Biol (1994) 3.76
RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol Rev (1996) 3.36
Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev (2000) 2.63
Coupled translation and replication of poliovirus RNA in vitro: synthesis of functional 3D polymerase and infectious virus. J Virol (1993) 2.38
A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J Virol (1994) 2.35
A common RNA structural motif involved in the internal initiation of translation of cellular mRNAs. Nucleic Acids Res (1997) 2.05
Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol (1994) 2.00
Picornavirus internal ribosome entry segments: comparison of translation efficiency and the requirements for optimal internal initiation of translation in vitro. Nucleic Acids Res (1995) 1.86
Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA. J Virol (1996) 1.85
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J Virol (1994) 1.80
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol (1992) 1.73
Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display. Mol Cell Biol (1999) 1.69
Cis-acting RNA elements in human and animal plus-strand RNA viruses. Biochim Biophys Acta (2009) 1.67
Conserved RNA secondary structures in Picornaviridae genomes. Nucleic Acids Res (2001) 1.62
Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol (1992) 1.56
A single nucleotide substitution in the internal ribosome entry site of foot-and-mouth disease virus leads to enhanced cap-independent translation in vivo. J Virol (1993) 1.50
Mutational analysis of the J-K stem-loop region of the encephalomyocarditis virus IRES. J Virol (1995) 1.49
Construction of an infectious cDNA clone of Aichi virus (a new member of the family Picornaviridae) and mutational analysis of a stem-loop structure at the 5' end of the genome. J Virol (2001) 1.48
Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol (2000) 1.47
Conserved tertiary structural elements in the 5' nontranslated region of cardiovirus, aphthovirus and hepatitis A virus RNAs. Nucleic Acids Res (1993) 1.46
Diagnosis of hepatitis a virus infection: a molecular approach. Clin Microbiol Rev (2006) 1.42
Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA. J Virol (1993) 1.40
The 5'-end sequence of the genome of Aichi virus, a picornavirus, contains an element critical for viral RNA encapsidation. J Virol (2003) 1.36
Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol (1996) 1.34
A search for structurally similar cellular internal ribosome entry sites. Nucleic Acids Res (2007) 1.29
Minimum internal ribosome entry site required for poliovirus infectivity. J Virol (1993) 1.25
trans complementation by RNA of defective foot-and-mouth disease virus internal ribosome entry site elements. J Virol (1994) 1.23
Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation. J Virol (1998) 1.22
Encephalomyocarditis virus internal ribosomal entry site RNA-protein interactions. J Virol (1994) 1.14
Absence of internal ribosome entry site-mediated tissue specificity in the translation of a bicistronic transgene. J Virol (1999) 1.13
Conditional rather than absolute requirements of the capsid coding sequence for initiation of methionine-independent translation in Plautia stali intestine virus. J Virol (2003) 1.10
The 5'-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis. J Virol (2005) 1.08
RNA-protein interactions at the 3' end of the hepatitis A virus RNA. J Virol (1996) 1.04
Detailed analysis of the requirements of hepatitis A virus internal ribosome entry segment for the eukaryotic initiation factor complex eIF4F. J Virol (2001) 1.01
Evolutionary origins of hepatitis A virus in small mammals. Proc Natl Acad Sci U S A (2015) 1.01
The mechanism of translation initiation on Aichivirus RNA mediated by a novel type of picornavirus IRES. EMBO J (2011) 1.01
In vivo and in vitro identification of structural and sequence elements of the human parechovirus 5' untranslated region required for internal initiation. J Virol (2000) 1.00
Replication of hepatitis A viruses with chimeric 5' nontranslated regions. J Virol (1996) 0.99
Replication of subgenomic hepatitis A virus RNAs expressing firefly luciferase is enhanced by mutations associated with adaptation of virus to growth in cultured cells. J Virol (2002) 0.98
Epidemiology and genetic characterization of hepatitis A virus genotype IIA. J Clin Microbiol (2010) 0.94
Function of a 5'-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J Virol (1995) 0.93
Identification of a conserved RNA replication element (cre) within the 3Dpol-coding sequence of hepatoviruses. J Virol (2008) 0.93
Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation. Nucleic Acids Res (2007) 0.92
Tricks an IRES uses to enslave ribosomes. Trends Microbiol (2012) 0.92
Temperature-sensitive hepatitis A virus mutants with deletions downstream of the first pyrimidine-rich tract of the 5' nontranslated RNA are impaired in RNA synthesis. J Virol (1995) 0.90
Internal ribosomal entry site-mediated translation initiation in equine rhinitis A virus: similarities to and differences from that of foot-and-mouth disease virus. J Virol (2000) 0.88
Gene expression and regulation from the p7 promoter of Aedes densonucleosis virus. J Virol (1998) 0.86
Cell proteins bind to a linear polypyrimidine-rich sequence within the 5'-untranslated region of rhinovirus 14 RNA. J Virol (1995) 0.84
Progress toward the development of a genetically engineered attenuated hepatitis A virus vaccine. J Virol (1996) 0.83
Nucleotide variability and translation efficiency of the 5' untranslated region of hepatitis A virus: update from clinical isolates associated with mild and severe hepatitis. J Virol (2010) 0.82
Ultra-deep sequencing analysis of the hepatitis A virus 5'-untranslated region among cases of the same outbreak from a single source. Int J Med Sci (2013) 0.81
Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites. PLoS One (2013) 0.79
A leaderless genome identified during persistent bovine coronavirus infection is associated with attenuation of gene expression. PLoS One (2013) 0.78
Molecular evolution of hepatitis A virus in a human diploid cell line. World J Gastroenterol (2007) 0.78
Discovery of a Novel Hepatovirus (Phopivirus of Seals) Related to Human Hepatitis A Virus. MBio (2015) 0.78
Viral internal ribosome entry site structures segregate into two distinct morphologies. J Virol (2003) 0.77
Functional binding of hexanucleotides to 3C protease of hepatitis A virus. Nucleic Acids Res (2011) 0.77
Full-length genome of wild-type hepatitis A virus (DL3) isolated in China. World J Gastroenterol (2003) 0.75
Improving virus production through quasispecies genomic selection and molecular breeding. Sci Rep (2016) 0.75
A novel hepatovirus identified in wild woodchuck Marmota himalayana. Sci Rep (2016) 0.75
Modification of the internal ribosome entry site element impairs the growth of foot-and-mouth disease virus in porcine-derived cells. J Gen Virol (2016) 0.75
Full-length genomic sequence of subgenotype IIIA hepatitis A virus isolate in Republic of Korea. Biomed Res Int (2013) 0.75
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1992) 0.75
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell (1986) 42.45
The scanning model for translation: an update. J Cell Biol (1989) 31.23
Improved free-energy parameters for predictions of RNA duplex stability. Proc Natl Acad Sci U S A (1986) 19.52
Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature (1988) 19.07
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol (1989) 7.01
A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. Cell (1990) 6.85
5'-terminal structure of poliovirus polyribosomal RNA is pUp. Proc Natl Acad Sci U S A (1976) 6.78
Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev (1990) 6.64
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J Virol (1984) 4.54
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49
A cellular protein that binds to the 5'-noncoding region of poliovirus RNA: implications for internal translation initiation. Genes Dev (1989) 4.35
Conserved structural domains in the 5'-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology (1989) 4.22
New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol (1989) 4.09
Regulation of translation by poliovirus. Adv Virus Res (1987) 4.08
Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol (1986) 3.94
An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis. J Virol (1988) 3.93
Initiation of encephalomyocarditis virus RNA translation: the authentic initiation site is not selected by a scanning mechanism. EMBO J (1990) 3.92
Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs. Nucleic Acids Res (1989) 3.81
Comparative sequence analysis of the 5' noncoding region of the enteroviruses and rhinoviruses. Virology (1988) 3.30
Prediction of RNA secondary structure, including pseudoknotting, by computer simulation. Nucleic Acids Res (1990) 3.15
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA. Proc Natl Acad Sci U S A (1989) 2.65
An RNA hairpin at the extreme 5' end of the poliovirus RNA genome modulates viral translation in human cells. J Virol (1991) 2.63
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A (1987) 2.56
Translation in mammalian cells of a gene linked to the poliovirus 5' noncoding region. Science (1988) 2.53
Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc Natl Acad Sci U S A (1990) 2.52
Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology (1988) 2.51
Primary structure and gene organization of human hepatitis A virus. Proc Natl Acad Sci U S A (1985) 2.43
Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNA. J Virol (1981) 2.40
An internal 5'-noncoding region required for translation of poliovirus RNA in vitro. J Virol (1988) 2.29
Phylogenetic comparative analysis of RNA secondary structure. Methods Enzymol (1989) 2.18
A guide for probing native small nuclear RNA and ribonucleoprotein structures. Methods Enzymol (1989) 2.15
The entire nucleotide sequence of the genome of human hepatitis A virus (isolate MBB). Virus Res (1987) 1.83
Molecular cloning and partial sequencing of hepatitis A viral cDNA. J Virol (1985) 1.82
A cellular 57 kDa protein binds to two regions of the internal translation initiation site of foot-and-mouth disease virus. FEBS Lett (1990) 1.78
Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA. J Virol (1989) 1.45
Effect of hepatitis A virus infection on cell metabolism in vitro. Proc Soc Exp Biol Med (1984) 1.32
Dideoxy sequencing of RNA using reverse transcriptase. Methods Enzymol (1989) 1.18
Nucleotide sequence of high-passage hepatitis A virus strain HM175: comparison with wild-type and cell culture-adapted strains. J Gen Virol (1989) 1.12
Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV. J Virol (1989) 1.02
Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res (1992) 4.58
Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures. J Clin Microbiol (1983) 3.20
Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA (1996) 3.14
Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology (1996) 3.14
A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol (1999) 3.13
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet (1997) 3.11
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
Type A viral hepatitis. New developments in an old disease. N Engl J Med (1985) 2.86
Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol (1992) 2.74
The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication. RNA (1998) 2.61
Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc Natl Acad Sci U S A (1990) 2.52
Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology (1988) 2.51
Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination. J Virol (1991) 2.36
Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol (1985) 2.20
Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water. N Engl J Med (1982) 2.07
Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology (2000) 2.05
Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA (1985) 2.03
Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J Virol (1994) 2.00
Transmission of hepatitis A virus among recently captured Panamanian owl monkeys. J Med Virol (1982) 1.94
Detection of hepatitis A virus in environmental samples by antigen-capture PCR. Appl Environ Microbiol (1994) 1.87
Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA. J Virol (1996) 1.85
Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay. Infect Immun (1980) 1.79
Internal ribosome entry site-mediated translation in hepatitis C virus replication. Curr Top Microbiol Immunol (2000) 1.78
The influence of downstream protein-coding sequence on internal ribosome entry on hepatitis C virus and other flavivirus RNAs. RNA (2001) 1.77
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA (1988) 1.76
Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg (2000) 1.75
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J Virol (1992) 1.73
Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis (1993) 1.62
A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet (1986) 1.61
Replication of EBV in epithelial cells during infectious mononucleosis. Nature (1977) 1.61
Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures. J Clin Microbiol (1984) 1.61
Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J Virol (2001) 1.59
Horizontal transmission of hepatitis B virus. Lancet (1989) 1.57
Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol (1992) 1.56
Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene (2011) 1.56
Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut (2010) 1.47
Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol (2000) 1.47
Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization. J Virol (1996) 1.46
The influence of low-, normal-, and high-carbohydrate meals on blood pressure in elderly patients with postprandial hypotension. J Gerontol A Biol Sci Med Sci (2001) 1.45
Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol (1998) 1.44
Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. J Biol Chem (1996) 1.40
Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA. J Virol (1993) 1.40
[Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for treatment]. Ned Tijdschr Geneeskd (1998) 1.40
Use of diuretics and opportunities for withdrawal in a Dutch nursing home population. Neth J Med (1998) 1.39
Combined immunoaffinity cDNA-RNA hybridization assay for detection of hepatitis A virus in clinical specimens. J Clin Microbiol (1985) 1.35
Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J Virol (1996) 1.34
Antigenic relatedness of two strains of hepatitis A virus determined by cross-neutralization. Infect Immun (1983) 1.29
Mutational analysis of the GB virus B internal ribosome entry site. J Virol (2000) 1.29
Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol (1996) 1.29
A military community outbreak of hepatitis type A related to transmission in a child care facility. Am J Epidemiol (1980) 1.27
Experimental infection of the New World owl monkey (Aotus trivirgatus) with hepatitis A virus. Infect Immun (1983) 1.27
Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol (1990) 1.25
An infectious cDNA clone of a cytopathic hepatitis A virus: genomic regions associated with rapid replication and cytopathic effect. Virology (1995) 1.24
Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin. Gastroenterology (1985) 1.24
Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol (2000) 1.22
Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol (1987) 1.22
Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions. J Gen Virol (1985) 1.18
Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci U S A (1988) 1.18
In vivo replication and reversion to wild type of a neutralization-resistant antigenic variant of hepatitis A virus. J Infect Dis (1990) 1.16
Immunoblot analysis demonstrates that the large and small forms of hepatitis delta virus antigen have different C-terminal amino acid sequences. J Gen Virol (1992) 1.16
Simultaneous infection with multiple herpesviruses. Am J Med (1979) 1.15
Serum neutralizing antibody response to hepatitis A virus. J Infect Dis (1983) 1.15
Structural basis of the oligomerization of hepatitis delta antigen. Structure (1998) 1.14
Recent advances in hepatitis A vaccine development. Virus Res (1990) 1.13
Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection. Infect Immun (1995) 1.13
Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin. J Infect Dis (1987) 1.12
Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med (1986) 1.10
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol (2000) 1.10
Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology (1995) 1.09
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob Agents Chemother (1994) 1.08
Inhibition of hepatitis B virus in tissue culture by alpha interferon. Antimicrob Agents Chemother (1994) 1.06
Genetic, antigenic and biological differences between strains of hepatitis A virus. Vaccine (1992) 1.06
Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol (2000) 1.06
Hepatitis delta virus mutant: effect on RNA editing. J Virol (1995) 1.05
Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronically infected homosexual men. J Infect Dis (1987) 1.05
Self-association of a synthetic peptide from the N terminus of the hepatitis delta virus protein into an immunoreactive alpha-helical multimer. Proc Natl Acad Sci U S A (1995) 1.05
Hepatitis delta virus antigen forms dimers and multimeric complexes in vivo. J Virol (1993) 1.05
Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology (2000) 1.04
Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV. J Virol (1989) 1.02
GB virus C, hepatitis G virus, or human orphan flavivirus? Hepatology (1997) 1.02
Infectious hepatitis A virus particles produced in cell culture consist of three distinct types with different buoyant densities in CsCl. J Virol (1985) 1.01
Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters. Infect Immun (1992) 1.00
Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes. J Virol (2000) 1.00
Normal mammary cells in long term culture. I. development of hormone-dependent functional monolayer cultures and assay of alpha-lactalbumin production. Endocrinology (1981) 1.00
Cerebral oxygenation declines in healthy elderly subjects in response to assuming the upright position. Stroke (2000) 0.99
The role of secretory immunity in hepatitis A virus infection. J Infect Dis (1991) 0.98
Attenuation phenotype of a cell culture-adapted variant of hepatitis A virus (HM175/p16) in susceptible New World owl monkeys. J Infect Dis (1993) 0.97